Terns Pharmaceuticals, Inc.

Q4 2025 13F Holders

Symbol
TERN
CUSIP
880881107
Type
Equity
Class
COM
Num filers
250
Total reported value, excl. options
$4.95B
Manager Report Date Value ($000) Shares